The situation with the coronavirus (COVID-19) is rapidly evolving as the virus is spreading in countries around the globe, including in the United States. This can make it challenging for your veterinary practice to know how to respond, and it’s important to revisit policies and procedures daily.
The opioid shortage isn’t going away any time soon. The shortage, which is severely affecting veterinarians’ ability to provide pain management for patients, is expected to last into 2019. The primary short-term cause is a production issue at a Pfizer, Inc. plant in Kansas, but residual hurricane damage in Puerto Rico, a major pharmaceutical manufacturing center, and a pre-existing Drug Enforcement Agency mandate to reduce the manufacture of opioid medication in the United States by 20% in 2018, are also having an effect.